CBT
Undervalued by 23.4% based on the discounted cash flow analysis.
Market cap | $3.93 Billion |
---|---|
Enterprise Value | $5.05 Billion |
Dividend Yield | $1.74 (2.37737395819101%) |
Earnings per Share | $6.79 |
Beta | 0.85 |
Outstanding Shares | 54,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 9.13 |
---|---|
PEG | 76.67 |
Price to Sales | 1.05 |
Price to Book Ratio | 2.6 |
Enterprise Value to Revenue | 1.29 |
Enterprise Value to EBIT | 7.75 |
Enterprise Value to Net Income | 11 |
Total Debt to Enterprise | 0.26 |
Debt to Equity | 0.93 |
No data
No data